COVID-19 vaccines, the key to the door that leads us out of this pandemic?
When I started writing this blog, I just received the notification from the government that my year of birth –
How the pandemic brought me back to scientific research
A year ago, on March 16th 2020, tight restrictions were enforced to control the spread of SARS-CoV-2, the coronavirus, in
How do you read Covid numbers?
The COVID-19 lead discovery project at PPSC started by identifying a well-established target that governs viral entry into host cells.
Optimal Assay conditions? Does that exist?
The COVID-19 lead discovery project at PPSC started by identifying a well-established target that governs viral entry into host cells.
How to accelerate drug discovery?
Fleur joined PPSC just before the pandemic started. In this blog she shares with us how she got off to a flying start by setting up research for COVID-19 medicines.
In a paper recently published in the SLAS Discovery Journal of Biomolecular Screening, European Lead Factory (ELF) scientists from Pivot
Assay development is often based on existing protocols, but a bit of luck can do no harm!
Fleur joined PPSC just before the pandemic started. In this blog she shares with us how she got off to a flying start by setting up research for COVID-19 medicines.
Honarnejad, S., van Boeckel, S., van den Hurk, H., & van Helden, S. (2020). Hit Discovery for Public Target Programs
The European Lead Factory selects first COVID-19 proposal
Over the last few months, as the world has grappled with the COVID-19 pandemic, the European Lead Factory has been
One of the sub-projects of the MMV-PDP Consortium recently received funding from the Bill and Melinda Gates Foundation, to further develop an
ZeGlobalTox – a rapid and reliable preclinical screening tool
The zebrafish (Danio rerio) is a tropical fish with a genetic structure surprisingly similar to ours. However, they’ve become a
Novel Screening Assay for Arginase-1 Inhibitors published in SLAS Discovery
Arginase-1 is a promising new drug target for cancer immunotherapy. A novel assay technology for High-Throughput Screening (HTS) of Arginase-1
Pivot Park – Banting Building (RE2423)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
